Share This Page
Drugs Containing Excipient (Inactive Ingredient) GLYCERIN
✉ Email this page to a colleague
Branded drugs containing GLYCERIN excipient, and estimated key patent expiration / generic entry dates
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | IDAMYCIN PFS | idarubicin hydrochloride | 0013-2576 | GLYCERIN | |
| Allergan Inc | RESTASIS MULTIDOSE | cyclosporine | 0023-5301 | GLYCERIN | |
| Allergan Inc | GELNIQUE | oxybutynin chloride | 0023-5812 | GLYCERIN | |
| Allergan Inc | ANDRODERM | testosterone | 0023-5990 | GLYCERIN | |
| Allergan Inc | CONDYLOX | podofilox | 0023-6118 | GLYCERIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Generic drugs containing GLYCERIN excipient
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Eli Lilly and Company | insulin lispro | 0002-7510 | GLYCERIN |
| Eli Lilly and Company | insulin lispro | 0002-7511 | GLYCERIN |
| Eli Lilly and Company | insulin lispro | 0002-7512 | GLYCERIN |
| Eli Lilly and Company | insulin glargine | 0002-7715 | GLYCERIN |
| Eli Lilly and Company | insulin lispro-aabc | 0002-7728 | GLYCERIN |
| >Company | >Ingredient | >NDC | >Excipient |
Glycerin: Pharmaceutical Excipient Market Dynamics and Financial Trajectory
Glycerin, a triol commonly used as a pharmaceutical excipient, exhibits stable market growth driven by its diverse applications as a solvent, humectant, and plasticizer. The global pharmaceutical excipients market is projected to reach $12.4 billion by 2028, with glycerin occupying a significant segment due to its cost-effectiveness and broad regulatory acceptance.
What is the Current Market Size and Growth Rate for Pharmaceutical-Grade Glycerin?
The global pharmaceutical excipients market, encompassing glycerin, is estimated to be valued at approximately $9.2 billion in 2023. This market is forecast to expand at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2028, reaching an estimated $12.4 billion by the end of the forecast period [1]. Pharmaceutical-grade glycerin constitutes a notable portion of this market, driven by its consistent demand across various drug formulations.
Key Market Drivers for Glycerin
- Increasing Pharmaceutical Production: The global rise in drug manufacturing, particularly in emerging economies, directly correlates with the demand for excipients like glycerin [2].
- Versatility of Applications: Glycerin's properties as a solvent, humectant, plasticizer, and sweetener make it suitable for a wide array of pharmaceutical products, including oral liquids, semi-solids, and solid dosage forms [3].
- Cost-Effectiveness: Compared to many synthetic excipients, glycerin offers a cost-effective solution for formulators, enhancing its attractiveness for manufacturers [4].
- Regulatory Acceptance: Glycerin is widely recognized and approved by major regulatory bodies, including the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), facilitating its global adoption [5].
- Growth in Biopharmaceuticals: The expanding biopharmaceutical sector, which often requires specialized formulation components, contributes to the demand for high-purity glycerin [6].
Geographic Market Segmentation
The pharmaceutical excipients market, including glycerin, is geographically segmented as follows:
- North America: Holds a significant market share due to its advanced pharmaceutical R&D infrastructure and robust manufacturing base [1].
- Europe: A mature market with stringent quality standards, driving demand for high-purity glycerin [1].
- Asia Pacific: Expected to witness the fastest growth, fueled by increasing pharmaceutical production, rising healthcare expenditure, and a growing number of generic drug manufacturers [7].
- Latin America and Middle East & Africa: Smaller but developing markets with potential for future growth [1].
What are the Primary Applications of Glycerin in Pharmaceutical Formulations?
Glycerin's multifaceted physicochemical properties enable its use in a diverse range of pharmaceutical dosage forms. Its primary functions include:
- Solvent: Glycerin can dissolve poorly soluble active pharmaceutical ingredients (APIs), aiding in drug delivery and bioavailability [3]. It is particularly effective for polar compounds.
- Humectant: Its hygroscopic nature allows it to retain moisture, preventing drying out in semi-solid formulations like creams and ointments, and improving the palatability of oral liquids [3].
- Plasticizer: In polymer-based drug delivery systems, such as coatings for tablets or films, glycerin enhances flexibility and reduces brittleness [8].
- Sweetener and Flavor Enhancer: Its sweet taste makes it a suitable excipient for pediatric formulations and oral solutions where palatability is critical [5].
- Preservative: Glycerin can contribute to the antimicrobial preservation of certain formulations by lowering water activity [9].
- Viscosity Modifier: It can increase the viscosity of liquid formulations, improving their texture and ease of administration [3].
Specific Dosage Form Examples
- Oral Liquids: Syrups, elixirs, suspensions, and solutions, particularly for cough and cold preparations and antibiotics.
- Semi-Solids: Creams, ointments, lotions, and gels for topical and transdermal drug delivery.
- Solid Dosage Forms: Used in tablet coatings, capsule shells, and as a binder in certain tablet formulations.
- Parenteral Formulations: In specific concentrations, glycerin can be used as a co-solvent or tonicity agent in injectable solutions, although its use here is more restricted due to potential side effects at higher concentrations [10].
What is the Competitive Landscape for Glycerin Manufacturers?
The market for pharmaceutical-grade glycerin is characterized by a mix of large multinational chemical companies and specialized excipient manufacturers. Key players focus on ensuring high purity, consistent quality, and compliance with pharmaceutical standards.
Major Glycerin Manufacturers and Suppliers
- BASF SE: A leading global chemical producer with a significant portfolio of pharmaceutical excipients, including high-purity glycerin.
- Dow Chemical Company: Offers a range of polyols, including glycerin, for pharmaceutical applications.
- Wilmar International Limited: A major agribusiness group with substantial glycerin production, supplying pharmaceutical grades.
- Croda International Plc: Specializes in high-performance ingredients and excipients for the pharmaceutical industry, including glycerin.
- Solvay SA: A chemical company providing a diverse range of specialty chemicals, including excipients.
- Emery Oleochemicals: Focuses on oleochemicals, including glycerin derived from natural sources.
Competitive Strategies
Manufacturers compete on several fronts:
- Product Quality and Purity: Meeting stringent pharmacopeial standards (e.g., USP, EP, JP) is paramount [5].
- Supply Chain Reliability: Ensuring consistent availability and timely delivery to pharmaceutical manufacturers globally [2].
- Regulatory Compliance and Documentation: Providing comprehensive regulatory support and documentation required for drug approval processes [11].
- Technical Support: Offering formulation expertise and troubleshooting assistance to drug developers [4].
- Sustainability: Increasingly, manufacturers are highlighting their commitment to sustainable sourcing and production practices, especially for bio-derived glycerin [12].
What are the Key Regulatory Considerations for Pharmaceutical-Grade Glycerin?
Regulatory compliance is critical for pharmaceutical excipients. Glycerin must meet specific pharmacopeial standards and be produced under Good Manufacturing Practices (GMP).
Key Pharmacopeial Standards
- United States Pharmacopeia (USP): Glycerin USP specifications define its purity, identification tests, and limits for impurities such as heavy metals, chloride, and sulfate [5].
- European Pharmacopoeia (EP): Similar standards to USP, ensuring interchangeability and quality across European markets [5].
- Japanese Pharmacopoeia (JP): Sets forth specifications for glycerin used in Japanese pharmaceutical products [5].
Good Manufacturing Practices (GMP)
Manufacturers of pharmaceutical-grade glycerin must adhere to GMP guidelines, which cover:
- Quality Management Systems: Robust systems for ensuring product quality and consistency.
- Facility and Equipment Design: Appropriate design, maintenance, and calibration of manufacturing facilities and equipment.
- Personnel Training: Ensuring personnel are adequately trained in GMP principles.
- Raw Material Control: Strict control and testing of incoming raw materials.
- Process Control and Validation: Documented and validated manufacturing processes.
- Packaging and Labeling: Appropriate packaging and labeling to maintain product integrity and provide essential information.
- Record Keeping and Traceability: Comprehensive records for traceability from raw material to finished product [11].
Impurity Profiling
Key impurities to control in pharmaceutical-grade glycerin include:
- Heavy Metals: Limits are set to ensure patient safety.
- Diethylene Glycol (DEG): A toxic impurity that has been the subject of significant regulatory scrutiny following past incidents. Manufacturers must demonstrate stringent control over its presence [13].
- Acids and Alkalis: Limits on residual acidity or alkalinity.
- Chlorides and Sulfates: Limits on inorganic contaminants.
What is the Financial Trajectory and Profitability Outlook for Glycerin Producers?
The financial outlook for pharmaceutical-grade glycerin producers is generally stable, characterized by consistent demand and relatively predictable pricing. Profitability is influenced by raw material costs, manufacturing efficiency, and the ability to command a premium for pharmaceutical-grade products.
Pricing Dynamics
- Raw Material Costs: The primary feedstock for glycerin production is often derived from fats and oils (animal or vegetable) or petrochemicals. Fluctuations in the prices of these commodities directly impact glycerin production costs. Crude glycerin prices can range from $300 to $600 per metric ton depending on feedstock and market conditions [14].
- Grade Differentiation: Pharmaceutical-grade glycerin, with its higher purity and stringent quality controls, commands a higher price than industrial or technical grades. The price premium can range from 10% to 30% or more, depending on the specific grade and supplier [4].
- Supply and Demand: While demand is generally stable, short-term supply disruptions or surges in demand for specific formulations can lead to temporary price adjustments.
- Geographic Market: Prices can vary regionally due to local production costs, import duties, and distribution expenses.
Profitability Factors
- Economies of Scale: Larger manufacturers benefit from economies of scale, reducing per-unit production costs.
- Process Efficiency: Optimizing manufacturing processes to minimize waste and energy consumption is crucial for profitability.
- Value-Added Services: Companies that offer strong regulatory support, technical expertise, and reliable supply chains can command higher margins.
- Vertical Integration: Some companies may integrate backward into oleochemical production or forward into specialized excipient formulations to capture more value.
- Market Access: Securing long-term contracts with major pharmaceutical companies provides revenue stability.
Investment Outlook
The investment outlook for glycerin production is largely tied to the overall growth of the pharmaceutical excipients market. While glycerin is a mature product, consistent demand and its essential role in many formulations make it a stable investment. Companies that can innovate in terms of sustainable sourcing, enhanced purity, or novel delivery applications might see greater growth potential. Acquisitions of smaller, specialized excipient manufacturers by larger chemical companies are also a likely trend.
What are the Potential Risks and Challenges in the Glycerin Market?
Despite its stable outlook, the glycerin market faces several risks and challenges.
Key Risks and Challenges
- Raw Material Price Volatility: Significant price swings in the cost of vegetable oils, animal fats, or petrochemicals can impact profitability [14].
- Regulatory Changes: Evolving regulatory requirements for impurities or manufacturing standards could necessitate costly process adjustments [13].
- Competition from Alternative Excipients: While glycerin is well-established, the development of novel excipients with superior properties or specialized functions could displace its use in certain niche applications.
- Supply Chain Disruptions: Geopolitical events, natural disasters, or pandemics can disrupt the supply of raw materials or finished glycerin, impacting availability and pricing.
- Sustainability Concerns: Increasing pressure for sustainable sourcing and production methods can require investment in new technologies and practices. For bio-derived glycerin, concerns about land use and competition with food crops can arise [12].
- Quality Control Incidents: Past incidents involving contaminated glycerin (e.g., Diethylene Glycol contamination) highlight the critical importance of robust quality control systems and the potential reputational and financial damage from such events [13].
Mitigation Strategies
- Diversification of Feedstocks: Sourcing glycerin from multiple types of feedstocks can mitigate reliance on any single commodity.
- Long-Term Contracts: Securing long-term supply agreements for raw materials can help stabilize costs.
- Robust Quality Assurance: Investing in state-of-the-art analytical equipment and rigorous quality control protocols to detect and prevent impurities.
- Process Optimization: Continuous improvement in manufacturing processes to enhance efficiency and reduce environmental impact.
- Strategic Partnerships: Collaborating with raw material suppliers and end-users to ensure supply chain resilience.
Key Takeaways
- The pharmaceutical excipients market, including glycerin, is projected to grow at a CAGR of 4.9% through 2028, reaching $12.4 billion.
- Glycerin's versatility as a solvent, humectant, and plasticizer, coupled with its cost-effectiveness and regulatory acceptance, underpins its consistent demand.
- The Asia Pacific region is expected to be the fastest-growing market for pharmaceutical excipients.
- Key manufacturers focus on product purity, supply chain reliability, and regulatory compliance.
- Strict adherence to pharmacopeial standards (USP, EP, JP) and GMP is essential for pharmaceutical-grade glycerin.
- Profitability is driven by economies of scale, process efficiency, and the ability to maintain quality and regulatory compliance.
- Risks include raw material price volatility, stringent regulatory oversight, and potential supply chain disruptions.
FAQs
-
What is the typical purity level for pharmaceutical-grade glycerin? Pharmaceutical-grade glycerin typically meets USP, EP, or JP monographs, requiring a minimum purity of 99.5% on a dry basis, with strict limits on impurities like heavy metals and diethylene glycol.
-
How does glycerin's price compare to other common pharmaceutical solvents like ethanol or propylene glycol? Glycerin is generally more expensive than ethanol but often comparable to or slightly more expensive than propylene glycol, depending on market conditions and grade. Its cost-effectiveness is relative to its performance and regulatory advantages in specific applications.
-
Are there any significant environmental concerns associated with glycerin production? When derived from natural sources like vegetable oils, glycerin production can raise concerns about land use, water consumption, and deforestation. However, advancements in sustainable sourcing and the increasing availability of glycerin as a byproduct of biodiesel production are addressing some of these issues. Petrochemical-derived glycerin has its own environmental footprint related to fossil fuel extraction and processing.
-
What are the primary differences between glycerin derived from petrochemical sources versus oleochemical sources? While chemically identical (C3H8O3), the distinction lies in the feedstock. Petrochemical glycerin is synthesized from propylene. Oleochemical glycerin is a byproduct of fat splitting or transesterification of natural fats and oils. Pharmaceutical manufacturers often prefer glycerin derived from controlled oleochemical processes or highly purified synthetic routes to ensure consistent impurity profiles.
-
What is the expected impact of the growing biopharmaceutical sector on glycerin demand? The biopharmaceutical sector's expansion is expected to contribute to glycerin demand as it requires specialized excipients for complex formulations, including cell culture media and protein stabilization. High-purity glycerin may find increased use in these advanced therapeutic applications.
Citations
[1] Grand View Research. (2023). Pharmaceutical Excipients Market Size, Share & Trends Analysis Report. [2] MarketsandMarkets. (2023). Pharmaceutical Excipients Market by Type, Functionality, Formulation, Application and Region - Global Forecast to 2028. [3] Banker, G. S., & Rhodes, C. T. (Eds.). (2009). Modern Pharmaceutics: Preformulation and Formulation of Drugs. CRC Press. [4] IQVIA Market Insights. (Internal analysis of excipient market trends). [5] United States Pharmacopeial Convention. (2023). The United States Pharmacopeia and The National Formulary (USP-NF). [6] BioPlan Associates. (2023). 17th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production. [7] Mordor Intelligence. (2023). Asia Pacific Pharmaceutical Excipients Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028). [8] Aulton, M. J. (2013). Aulton's Pharmaceutics: The Science of Dosage Form Design. Elsevier Health Sciences. [9] Lambert, R. J. W., & Pearson, J. (2000). Glycerol and the glycols. In Disinfection, sterilization and preservation (pp. 133-151). ASM Press. [10] Yalkowsky, S. H., & He, X. (2003). The Chemical and Physical Properties of Drugs. Pharmaceutical Press. [11] U.S. Food and Drug Administration. (2023). Guidance for Industry on Current Good Manufacturing Practice for Active Pharmaceutical Ingredients. [12] European Chemical Industry Council (CEFIC). (2022). Sustainability in the Chemical Industry Report. [13] World Health Organization. (2008). Glycerol contamination in pharmaceutical products. [14] Statista. (2023). Glycerin prices worldwide 2022.
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
Visit the Subscription Options page for details on plans and pricing.
ISSN: 2162-2639

Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Access the Complete Database
Make Better Decisions
- Identify first generic entrants
- Uncover prior art in expired and abandoned patents
- Obtain formulation and manufacturing information